SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models-Reference-Cited by-同舟云学术

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Published:2021-12-29 Issue:1 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Synn Chun‐Bong¹²^ORCID,Kim Sung Eun¹,Lee Hee Kyu³,Kim Min‐Hwan⁴,Kim Jae Hwan¹,Lee Ji Min²,Jo Ha Ni¹,Lee Wongeun⁵,Kim Dong Kwon¹^ORCID,Byeon Youngseon¹,Kim Young Seob¹,Yun Mi Ran⁵,Park Chae‐Won¹,Yun Jiyeon¹,Lim Sangbin¹,Heo Seong Gu¹,Yang San‐Duk¹,Lee Eun Ji¹^ORCID,Lee Seul¹,Choi Hunmi¹,Lee You Won¹,Cho Jae Seok¹,Kim Do Hee¹²,Park Sungho³,Kim Jung‐Ho³,Choi Yewon³,Lee Sung Sook⁶,Ahn Beung‐Chul⁴^ORCID,Kim Chang Gon⁴,Lim Sun Min⁴,Hong Min Hee⁴^ORCID,Kim Hye Ryun⁴,Pyo Kyoung‐Ho¹⁴^ORCID,Cho Byoung Chul⁴^ORCID

Affiliation:

1. Department of Medical Science College of Medicine Yonsei University Seoul Korea

2. Brain Korea 21 PLUS Project for Medical Science Yonsei University College of Medicine Seoul Korea

3. Oscotec Inc. Seongnam Korea

4. Yonsei Cancer Center Yonsei University College of Medicine Seoul Korea

5. JEUK Institute for Cancer Research Gumi Korea

6. Department of Hematology‐Oncology Inje University Haeundae Paik Hospital Busan Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject